20398 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
PAPD5 INHIBITORS AND METHODS OF USE THEREOF
#2FUSED RING COMPOUND HAVING GLP-1 RECEPTOR AGONIST EFFECT
#3KRAS INHIBITORS
#4Compositions and Methods for the Restoration of Ciliary Function
#5POLYSUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF
#6PREVENTION OF ROSACEA INFLAMMATION
#7ARTEMISININ-BASED COMBINATION THERAPY FOR TREATING VIRAL MEDIATED DISEASE
#8ENHANCED ARTEMISININ-BASED COMBINATION THERAPY FOR TREATING PARASITIC MEDIATED DISEASE
#9COMBINATION THERAPIES INVOLVING L-ASPARAGINASE
#10ENANTIOMER OF AZOPODOPHYLLOTOXIN DERIVATIVE SU056
#11SOLID COMPOSITION OF GLP-1 RECEPTOR AGONIST
#12THERAPEUTIC USES OF GLP1R AGONISTS
#13PRMT5 INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF
#14COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDER
#15COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#16ALBICIDIN DERIVATIVES, THEIR USE AND SYNTHESIS
#17USE OF DEXPRAMIPEXOLE FOR THE TREATMENT OF INADEQUATELY CONTROLLED MODERATE TO SEVERE ASTHMA
#18NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF
#19AZAPHILONE COMPOUND AND USE THEREOF IN PREPARATION OF ANTI-TUMOR DRUGS
#20POLYCYCLIC COMPOUND AND USE THEREOF
#21COMPOSITIONS OF AUTOPHAGY MODULATING AGENTS AND USES THEREOF
#22DERIVATIVES OF TURBINMICIN AS ANTIFUNGAL AGENTS
#23CYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#24SELECTIVE TREATMENT OF CANCERS HAVING HISTONE H3 MUTATIONS OR ABERRANT LEVELS OF DNA OR HISTONE METHYLATION, ACETYLATION OR DEFECTS IN HOMOLOGOUS RECOMBINATION
#25TRICYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#26METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION
#27Methods of treating or reducing symptoms of stimulant dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and glutamate allosteric modulators
#28Methods of treating or reducing symptoms of anxiety, depression, attention deficiency (ADD), attention deficient hyperactivity (ADHD), obsessive compulsive (OCD), Bipolar disorder, and related disorders/conditions via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and other allosteric modulators.
#29METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE
#30METHOD OF TREATING AND/OR PREVENTING TYPE 1 DIABETES WITH CEPHARANTHINE
#31NANOPARTICLES AND USES THEREOF FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS
#32FERROPTOSIS INHIBITOR AND USE THEREFOR
#33Methods of increasing effects of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, opiate allosteric modulators as/in foods, beverages, vaporizer, smoking and supplement products/formulations.
#34Methods of reducing symptoms of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, GLP-1 allosteric modulators as/in foods, beverages, vaporizer, smoking and supplement products/formulations.
#35Methods of reducing symptoms of the ingestion of drugs such as cannabis or 5ht2 agonists via applications with 5ht1/2, CB1, GLP-1 allosteric modulators where the method of delivery/formulation selected from: Inhaler, nebulizer, intravenously, intramuscularly, injection, capsules, tablets, pills.
#36Methods of treating or reducing symptoms of opiate dependency (addiction) via combination therapy with vaccine/antibodies and 5ht1/5ht2, SERT and opiate allosteric modulators
#37COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS
#38Methods of treating or reducing symptoms of nicotine dependency (addiction) such as tobacco-use (smoking, vaping, sublingual, oral) and/or tobacco smoking cessation via combination therapy with allosteric modulators and phenethylamines.
#39BCMA Monoclonal Antibody-Drug Conjugate
#40Methods of treating or reducing symptoms of brain cancer such as glioma and glioblastoma via combination therapy with allosteric modulators and phenethylamines.
#41Methods of use and formulations of allosteric modulators of the serotonin, dopamine and other receptor systems for medical, recreational, religious, research and other uses.
#42PRMT5 INHIBITORS AND USES THEREOF
#43SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#44Contact Lenses And Other Eye-Contacting Matrices Carrying Mitochondrially-Targeted Antioxidants
#45COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDER
#46METHODS, KITS AND COMPOSITIONS FOR REDUCING CHROMOSOMAL INSTABILITY IN CANCER CELLS
#47Inhibitors of RAD52 Recombination Protein and Methods Using Same
#48PROCESSES FOR THE PREPARATION OF SELECTIVE ESTROGEN RECEPTOR DEGRADERS
#49Macrophage Stimulating 1 Receptor (MST1R) Variants And Uses Thereof
#50APPLICATION OF ISOQUINOLINE COMPOUND IN TUMOR TREATMENT
#51CONJUGATE AND USE THEREOF
#52Method for inhibiting infection of SARS-CoV-2 in a Subject
#53INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS
#54Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
#55METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS
#56Therapeutic agent for treating bradyarrhythmia
#57THERAPEUTIC AGENT FOR DRUG-INDUCED BRADYCARDIA AND BRADYARRHYTHMIA
#58USE OF MULTIFUNCTIONAL LIGANDS FOR TREATING THE RESPIRATORY DISTRESS AND CYTOKINE STORM SYNDROMES ASSOCIATED WITH CORONAVIRUS VIRAL INFECTIONS
#59USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES, MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONS
#60Prevention of rosacea inflammation
#61COMPOSITIONS AND METHODS FOR TREATING, PREVENTING OR REVERSING AGE-ASSOCIATED INFLAMMATION AND DISORDERS
#62SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME
#63TREATMENT FOR CHEMOBRAIN
#64INHALED STATINS AS BRONCHODILATORS TO IMPROVE LUNG FUNCTION IN RESPIRATORY DISEASES
#65AZAPODOPHYLLOTOXIN DERIVATIVES AND METHODS OF TREATING LYMPHOMA AND KIDNEY CANCER
#66FORMULATION
#67Method for inhibiting Zika virus infection
#68Method for inhibiting dengue virus infection
#69Method for inhibiting Zika virus infection
#70Method for inhibiting dengue virus infection
#71Use of miloxacin in preparation of medicines for treating and/or preventing diseases with T-type calcium channels as therapeutic target
#72Selective estrogen receptor degraders
#73Treatment for epilepsy
#74Methods of use and formulations of allosteric modulators of the serotonin, dopamine and other receptor systems for medical, recreational, religious, research and other uses.
#75Methods of preventing or treating flavivirus virus infections and methods of inhibiting the entry of flvivirus, enterovirus or lentivirus into host cells
#76USE OF AN OPIOID MOLECULE FOR TREATING DRY EYE AND EYES SUFFERING FROM ALLERGIES
#77NEDOCROMIL SODIUM TO PREVENT, LIMIT ONSET, AND /OR TREAT PANCREATIC CANCER
#78COMPOUNDS AND TREATMENTS THAT ENHANCE ENTERIC NERVOUS SYSTEM FUNCTION
#79THERAPEUTIC AGENT FOR INHERITED BRADYARRHYTHMIA
#80Quinolin-2(1H)-one inhibitors of Late SV40 Factor
#81SELECTIVE TREATMENT OF CANCERS HAVING HISTONE H3 MUTATIONS OR ABERRANT LEVELS OF DNA OR HISTONE METHYLATION, ACETYLATION OR DEFECTS IN HOMOLOGOUS RECOMBINATION
#82LIPID PRODRUGS FOR USE IN DRUG DELIVERY
#83Treatment of Vascular Occlusion by Activation of Notch Signaling
#84BCMA monoclonal antibody-drug conjugate
#85Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
#86PAPD5 inhibitors and methods of use thereof
#87Furoquinolinediones as inhibitors of TDP2
#88Method for immunomodulation of using aza-podophyllotoxin derivatives
#89USE OF PHARMACEUTICAL COMPOSITION IN PREPARING DRUG AGAINST HELICOBACTER PYLORI
#90INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS
#91Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#92Methods of preventing or treating flavivirus virus infections and methods of inhibiting the entry of flvivirus, enterovirus or lentivirus into host cells
#93Macrophage stimulating 1 receptor (MST1R) variants and uses thereof
#94Inhibitors of RAD52 Recombination Protein and Methods Using Same
#95THERAPEUTIC USES OF GLP1R AGONISTS
#96Urea-substituted aromatic ring-linked dioxinoquinoline compounds, preparation method and uses thereof
#97KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
#98N-hydroxyethyl didehydroazapodophyllotoxins as GBP1 inhibitors and methods of overcoming treatment resistance in cancer
#99KV1.3 INHIBITORS AND THEIR MEDICAL APPLICATION
#100Compositions and methods for the treatment of fungal infections
#101Anti-flavivirus compounds and methods of use
#102Prevention of rosacea inflammation
#103Anti-flavivirus compounds and methods of use
#104TREATMENT OF EPILEPSY
#105CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE
#106Urea-substituted aromatic ring-linked dioxane-quinazoline and -linked dioxane-quinoline compounds, preparation method therefor and use thereof
#107MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS
#108Inhibitors of RAD52 recombination protein and methods using same
#109Natural compounds and fibrosis
#110THERAPY FOR DRUG-RESISTANT CANCER BY ADMINISTRATION OF ANTI-HER2 ANTIBODY/DRUG CONJUGATE
#111H4 agonist molecule for the treatment of idiopathic pulmonary fibrosis
#112MAST CELL STABILIZERS TREATMENT FOR SYSTEMIC DISORDERS
#113Antibody and checkpoint inhibitor combination therapy
#114Therapeutic compositions and methods of making and using the same
#115Sensitization of bacterial cells to quinolone antibiotics
#116Kv1.3 inhibitors and their medical application
#117Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#118Pulmonary hypertension preventative or therapeutic agent containing component exhibiting selenoprotein P activity-inhibiting effect
#119Mast cell stabilizers treatment for systemic disorders
#120Compositions and methods for the treatment of fungal infections
#121USE OF AN H4 AGONIST MOLECULE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
#122Melanin decomposition inhibitor
#123BCMA monoclonal antibody-drug conjugate
#124COMBINATION ANTICANCER ENDOWED WITH ANTITUMOR ACTIVITY, COMPRISING ALKALOIDS OF CHELIDONIUM MAJUS
#125Inhibition and treatment of bacterial infections by sex-specific GPER targeting
#126Method for inhibiting growth of cancer cells
#127Tetrandrine family pharmaceutical formulations and method
#128Piperidine derivative and preparation method and pharmaceutical use thereof
#129EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
#130Mast cell stabilizers treatment for systemic disorders
#131Inhibitors of the plasmodial surface anion channel as antimalarials
#132Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication
#133PREVENTION OF ROSACEA INFLAMMATION
#134Chemical entities that kill senescent cells for use in treating age-related disease
#135CONTACT LENSES CARRYING MITOCHONRIALLY-TARGETED ANTIOXIDANTS
#136Therapeutic targeting of myeloproliferative neoplasms by DUSP1 inhibition
#137COMPOSITIONS AND METHODS TO IMPROVE THE THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS INCLUDING SUBSTITUTED HEXITOLS SUCH AS DIANHYDROGALACTITOL AND DIACETYLDIANHYDROGALACTITOL
#138Inhibitors of RAD52 recombination protein and methods using same
#139THERAPEUTIC COMPOUNDS
#140Use of physiological cooling active ingredients, and agents containing such active ingredients
#141Compositions for use in the treatment of tumors resistant to chemotherapy
#142KV1.3 inhibitors and their medical application
#143Methods and compositions for unsilencing imprinted genes
#144Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#145Lactate dehydrogenase inhibitor and antiepileptic drug containing the same
#146Furoquinolinediones as inhibitors of TDP2
#147Compounds and methods for the treatment of drug resistance in cancer cells against paclitaxel
#148METHOD FOR TREATING CANCER USING TETRADRINE
#149Chemical entities that kill senescent cells for use in treating age-related disease
#150Mast cell stabilizers treatment for systemic disorders
#151Kinase inhibitors
#152Protein kinase C inhibitor for treating triple-negative breast cancer
#153Heterocyclic compounds and their use as retinoid-related orphan receptor (ROR) gamma-T inhibitors
#154ENCAPSULATION OF ISOQUINOLINE ALKALOIDS
#155Therapeutic compounds
#156Indexable cutting insert and milling tool
#157COMPOSITIONS AND METHODS FOR TREATING DIABETES
#158TETRANDRINE FAMILY PHARMACEUTICAL FORMULATIONS AND METHOD
#159Tetrandrine family pharmaceutical formulations and method
#160Mast cell stabilizers treatment for systemic disorders
#161Use of aryl-quinolin derivatives as inhibitors of vasculogenic mimicry
#162Tricyclic compounds and methods of making and using same
#163Mast cell stabilizers treatment for systemic disorders
#164Water soluble 4-azapodophyllotoxin analogs
#165Inhibitors of the plasmodial surface anion channel as antimalarials
#166NOVEL COMPOUND WITH ANTIBACTERIAL ACTIVITY
#167Method for Immunomodulation of using Aza-podophyllotoxin derivatives
#168Mast Cell Stabilizers to Prevent or Treat Laminitis
#169Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
#170N-substituted indenoisoquinolines and syntheses thereof
#171Compositions comprising rutin useful for the treatment of tumors resistant to chemotherapy
#172Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#173Heterocyclic compound
#174Heterocyclic compound
#175Heterocyclic compound
#176USE OF AN H4 AGONIST MOLECULE TO TREAT ACUTE LEUKEMIA
#177THERAPEUTIC COMPOUNDS
#178Inhibitors of viral replication, their process of preparation and their therapeutical uses
#179Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
#180Compositions and methods for the treatment of fungal infections
#181Combination Therapy for Subcutaneous Administration of Glycopeptide Antibiotics
#182Pharmaceutical composition for treating a microbial infection
#183Synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1)—topoisomerase I (Top1) inhibitors
#184METHODS AND COMPOSITIONS FOR MODULATING REGULATORY T CELL FUNCTION
#185Prevention of rosacea inflammation
#186FKBP52 TARGETING AGENT PHARMACEUTICAL COMPOSITIONS
#187Therapeutic compounds
#188Heterocyclic compound
#189MITOTIC KINESIN Eg5 INHIBITING ANTICANCER AGENTS
#190Substituted pyrano and furanoquinolines, their preparation and use as medicaments
#191Method of inhibiting ABCG2 and related treatments
#192TREATMENT OF MTOR HYPERACTIVE RELATED DISEASES AND DISORDERS
#193N-substituted indenoisoquinolines and syntheses thereof
#194Methods for novel drug discovery, treatment and selective targeting for gefitinib-resistant non-small-cell lung cancer harboring T790M mutation
#195Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
#196Hepatitis C virus inhibitors
#197Inhibitors of viral replication, their process of preparation and their therapeutical uses
#198Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#199Inhibitors of viral replication, their process of preparation and their therapeutical uses
#200N-substituted indenoisoquinolines and syntheses thereof
#201Artemisinin with berberine compositions and methods of making
#202Method for inhibiting growth of cancer cells
#203GPR17 receptor modulators
#204IN SITU CONTROLLED RELEASE DRUG DELIVERY SYSTEM
#205Kinase inhibitors
#206Tritoqualine for use in the treatment of cystic fibrosis
#207Use of physiological cooling active ingredients, and agents containing such active ingredients
#208Paralytic shellfish poison
#2092-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
#210METHODS OF INCREASING LIGHT RESPONSIVENESS IN A SUBJECT WITH RETINAL DEGENERATION
#211SUBSTITUTED CELLULOSE ACETATES AND USES THEREOF
#212GABAA RECEPTOR ANTAGONISTS AFFECTING GANGLION CELL FUNCTION AND VISUAL ACUITY
#213Positive allosteric modulators for melanocortin receptors
#214Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
#215Compounds and methods for inhibition of AP endonuclease-1/redox factor-1 (HAPE1) activity
#216NOVEL TREATMENT OF GEFITINIB-RESISTANT NON-SMALL-CELL LUNG CANCER
#217N-substituted indenoisoquinolines and syntheses thereof
#218INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
#219COMPOSITIONS AND METHODS FOR TREATING BRAIN CANCER
#220Method and products for enhancing drug and dietary supplement bioavailability
#221Tetrandrine family pharmaceutical formulations and method
#222Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#223NOVEL ANTI-CANCER ISOCARBOSTYRIL ALKALOID CONJUGATES
#224PROTEIN KINASE C AS A TARGET FOR THE TREATMENT OF RESPIRATORY SYNCYTIAL VIRUS
#225Tetrandrine pharmaceutical formulations
#226Macrocyclic inhibitors of hepatitis C virus
#227Natural product derivatives with antiprotozoal activity
#228SOLID STATE FORMS OF HIV INHIBITOR
#229Inhibitors of the plasmodial surface anion channel as antimalarials
#230Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#231Benzothiazole compounds and their pharmaceutical use
#232BOLDINE DERIVATIVES FOR PROMOTING BONE GROWTH
#233QUINOLINONE DERIVATIVES FOR USE IN THE TREATMENT OF AN AUTOIMMUNE DISEASE AND/OR AN INFLAMMATORY DISEASE
#234TREATMENTS FOR CELLULAR PROLIFERATIVE DISORDERS AND IDENTIFICATION THEREOF
#235Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics
#236Methods and compositions for unsilencing imprinted genes
#237Therapeutic compounds
#238Therapeutic compounds
#239COMPOSITION FOR PREVENTING OR TREATING DEMENTIA
#240Pharmaceutical composition and method of treating a microbial infection with sulcotidil
#241Mast cell stabilizers in the treatment of obesity
#242Noscapine analogs and their use in treating cancers
#243Crystalline forms of a hexahydrofuro[3,4-c]quinoline derivative
#244Inhibitors of human immunodeficiency virus replication
#245Substituted cellulose acetates and uses thereof
#246METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF
#247Nitrogenated derivatives of pancratistatin
#248Artemisinin with berberine compositions and methods of making
#249Pharmaceutical compositions useful for preventing and treating cancer
#250COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES
#251Uses of Noscapine and Derivatives in Subjects Diagnosed with FAP
#252Composition for obesity treatment
#253Compounds and compositions for treating infection
#254COMPOSITIONS CONTAINING SALMETEROL, FLUTICASONE AND CROMOGLICIC ACID
#255Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#256Methods for promoting epithelialization and healing of chronic wounds
#257Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor function and methods of using same
#258Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
#259Use of physiological cooling active ingredients, and agents containing such active ingredients
#260Anti-constipation composition
#261Topoisomerase inhibitors
#262Camptothecin derivatives
#263TREATMENT OF DYSKINESIA RELATED DISORDERS
#264N-substituted indenoisoquinolines and syntheses thereof
#265Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
#266Solid forms of a chemokine receptor antagonist and methods of use thereof
#267Anti-constipation composition
#268Compositions and methods for treating amyloidosis
#269Noscapine and Noscapine Analogs and Their Use in treating Infectious Diseases by Tubulin Binding Inhibition
#270Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
#271PHARMACEUTICAL COMPOSITION COMPRISING A BI-CYCLIC COMPOUND AND METHOD FOR STABILIZING THE BI-CYCLIC COMPOUND
#272Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
#273ANTI-FLAVIVIRUS THERAPEUTIC
#274Inhibition of filovirus entry into cells and uses thereof
#275Inhibitors of the plasmodial surface anion channel as antimalarials
#276Nitrogenated derivatives of pancratistatin
#277Carboxylic acid compound
#278Formulations with sanguinarine, chelerythrine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
#279Inhibitors of human immunodeficiency virus replication
#280MEMORY INFLUENCING PROTEIN
#281Medical Devices for Localized Drug Delivery
#282Medical Devices for Localized Drug Delivery
#283Inhibitors of human immunodeficiency virus replication
#284Method of inhibiting ABCG2 and related treatments
#285Combinations of botanical extracts for promoting cardiovascular health
#286NOSCAPINE ANALOGS AND THEIR USE IN TREATING CANCERS, INCLUDING DRUG-RESISTANT CANCERS
#287Method of preventing and/or treating a neurodegenerative disease by administering an extract of and/or a compound isolated therefrom
#288CHELERYTHRINE, ANALOGS THEREOF AND THEIR USE IN THE TREATMENT OF BIPOLAR DISORDER AND OTHER COGNITIVE DISORDERS
#289AQUEOUS PHARMACEUTICAL COMPOSITION
#290METHODS AND COMPOSITIONS FOR MODULATING INSULIN SECRETION AND GLUCOSE METABOLISM
#291MEMORY ENHANCING PROTEIN
#292Genipin derivatives and uses thereof
#293PHARMACEUTICAL COMPOSITION COMPRISING A CAMPOTHECIN DERIVATIVE
#294Pharmaceutical compositions useful for preventing and treating oncological diseases
#295Compounds and methods for treatment of alpha-1 antitrypsin deficiency
#296Thienopyridine and furopyridine kinase inhibitors
#297Targeted whole genome amplification method for identification of pathogens
#298Macrocyclic inhibitors of hepatitis C virus
#299Mast cell inhibition in diseases of the retina and vitreous
#300Mast cell stabilizers to prevent or treat laminitis